ResearchGate and Compuscript launch new partnership
ResearchGate, the professional network for researchers, and Compuscript, an independent open access publisher, have announced a Journal Home partnership that aims to foster the global reach and impact of Compuscript’s peer-reviewed medical, biotechnology, and scientific journals.
Five of Compuscript’s biomedical journals will now be immediately accessible to ResearchGate’s highly engaged global community of 25million+ researcher members, boosting readership and attracting new authors to these titles. The Journal Home partnership enables:
- Comprehensive engagement with researchers throughout the research and publishing cycle, building new opportunities for high-quality submissions and increasing author loyalty.
- High brand profile for journals through dedicated Journal Profiles, and prominent discoverability and accessibility across hundreds of touch points on the ResearchGate platform, including article pages, feeds, members’ profiles, notifications and searches.
- New author services, including automatically adding new articles to author profiles – providing them with key insights about their readers and engagement.
- Unique understanding of the researcher community engaging with their journals and how this grows and changes over time.
“Journal Home provides our journals with a highly contextual researcher-centric environment to engage researchers as readers and potential authors,” said Morgan Lyons, CEO, Compuscript. “We’re delighted to partner with ResearchGate to utilise Journal Home to raise the international profile of our journals and their research, as well as further enhance the service and impact we provide for our authors.”
“We’re delighted to welcome Compuscript to Journal Home, giving their journals new opportunities to grow international engagement, recognition and reach,” said Robyn Mugridge, Head of Partnership Development at ResearchGate. “This collaboration provides unrivalled opportunities for these journals to grow their communities of medical and biotechnology researchers, enabling new connections, collaborations, and discoveries.”